Ana Blasco-Cordellat

7PUBLICATIONS
35CO-AUTHORS
Continuing and community educationMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 16, 2026
A Decade of QOPI in Spain: From Quality Measurement to Continuous Improvement in Oncology Practice.

|Jan 28, 2026
Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody-drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology.

Margarita Majem, Kevin Molina Mata, Ander Mayor Ibarguren

|Nov 13, 2025
The Impact on the Therapeutic Decision of Massive Gene Sequencing (NGS) in Plasma from Patients with Advanced Non-Small Cell Lung Cancer (NSCLC).

Paula Llor-Rodriguez, Ana Blasco-Cordellat, Sonia Macia-Escalante

|Aug 21, 2023
Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Brain, GECP17/05).

Ernest Nadal, Delvys Rodríguez-Abreu, Marta Simó

|Jul 02, 2021
Characterization of Circulating T Cell Receptor Repertoire Provides Information about Clinical Outcome after PD-1 Blockade in Advanced Non-Small Cell Lung Cancer Patients.

Ning Dong, Andrea Moreno-Manuel, Silvia Calabuig-Fariñas

|Mar 26, 2021
SEOM clinical guidelines for anaemia treatment in cancer patients (2020).

Y Escobar Álvarez, R de Las Peñas Bataller, J Perez Altozano

Pageof 2

Frequent Collaborators

2 joint publications

Y Escobar Álvarez

2 joint publications

R de Las Peñas Bataller

2 joint publications

E Brozos Vázquez

2 joint publications

J Corral Jaime